about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
1.41
-0.08
(-5.37%)
75,006.3
XNAS Volume
XNAS 15 Apr, 2026 12:46 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
MetaVia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..